艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系

杨泽宇; 何小丽; 唐焘; 王迪; 廖雪梅; 余时沧

doi:10.16016/j.1000-5404.201903189

您当前的位置：

首页 >

文章列表页 >

艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系

基础医学 | 更新时间：2026-01-09

- 艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系
- Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer
- 第三军医大学学报 2019年41卷第17期页码：1635-1641
- 作者机构：
  
  1.400038 重庆，陆军军医大学(第三军医大学)第一附属医院:全军临床病理学研究所，西南癌症中心
  2.400038 重庆，陆军军医大学(第三军医大学)第一附属医院:干细胞与再生医学科
- 作者简介：
  
  [ 余时沧，E-mail:yushicang@163.com YU Shicang, E-mail:yushicang@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81572880)
- DOI：10.16016/j.1000-5404.201903189
  中图分类号： R345;R730.7;R735.3
- 收稿：2019-03-22，
  
  修回：2019-06-14，
  
  纸质出版：2019-09-15
- 稿件说明：
移动端阅览
杨泽宇, 何小丽, 唐焘, 等. 艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系[J]. 第三军医大学学报, 2019,41(17):1635-1641.

Zeyu YANG, Xiaoli HE, Tao TANG, et al. Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer[J]. Journal of Third Military Medical University, 2019, 41(17): 1635-1641.
杨泽宇, 何小丽, 唐焘, 等. 艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系[J]. 第三军医大学学报, 2019,41(17):1635-1641. DOI： 10.16016/j.1000-5404.201903189.

Zeyu YANG, Xiaoli HE, Tao TANG, et al. Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer[J]. Journal of Third Military Medical University, 2019, 41(17): 1635-1641. DOI： 10.16016/j.1000-5404.201903189.

摘要

目的

寻找与结直肠癌转移相关并具有预后预测意义的溶酶体分子。

方法

获取TCGA数据库结直肠癌数据集(Colon Adenocarcinoma TCGA-632)结直肠癌临床样本信息和基因转录组测序表达矩阵；通过基于LASSO(least absolute shrinkage and selection operator)算法的Logistic回归筛选与远处转移相关的溶酶体基因；进一步利用基于LASSO算法的COX回归模型，筛选与结直肠癌患者预后相关的基因，并选择回归系数最大的艾杜糖醛酸-2-硫酸酯酶(iduronic acid-2-sulfatase，IDS)进行研究；收集本院2007-2008年50例结直肠癌患者肿瘤组织标本进行免疫组织化学染色，分析组织中IDS表达量与转移及预后的关系。

结果

TCGA数据库分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N

1-2

: -0.103±0.073

0.303±0.123，

=0.003)；发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M

: 0.017±0.071

0.636±0.296，

=0.003)；IDS高表达患者的预后较低表达患者不良(总体生存期:

=0.008；无病生存期:

=0.007)；COX回归分析显示:IDS mRNA高表达是结直肠癌患者预后不良的独立预测因素(

=0.014，风险系数为2.651，95%

:1.217~5.775)；50例结直肠癌组织免疫组化分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N

1-3

: 27.324±0.698

40.674±3.528，

=3.0×10

-5

)；发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M

: 27.941±0.952

39.320±3.467，

=1.2×10

-5

)；IDS高表达患者预后不良(

=7.2×10

-5

)；COX回归分析显示:IDS高表达是预后不良的独立预测因素(

=0.008，风险系数为5.847，95%

:1.585~21.568)。

结论

IDS高表达的结直肠癌患者转移发生率高、预后差，IDS可作为结直肠癌患者独立预后预测因子。

Abstract

Objective

To select lysosomal molecules related to metastasis and prognosis of colorectal cancer.

Methods

The clinical sample information and gene transcriptome sequencing expression matrix of colorectal cancer TCGA database (Colon Adenocarcinoma TCGA-632) were obtained. The lysosomal genes associated with distant metastasis were screened by least absolute shrinkage and selection operator (LASSO)-based logistic regression. Further the LASSO-based COX regression model was employed to screen the genes closely related to prognosis of colorectal cancer patients. Among those genes

the iduronic acid-2-sulfatase (IDS) was selected because of its largest regression coefficient. Then

50 paraffin embedded colorectal cancer tissues harvested in our hospital from 2007 to 2008 were used for IDS immunohistochemistry staining. The relationships of IDS expression level in the tissues with metastasis and prognosis of colorectal cancer were analyzed.

Results

The results of TCGA database analysis showed that the relative mRNA expression level of IDS was significantly higher in the colorectal cancer patients with lymph node metastasis than those without (N

1-2

: -0.103±0.073

0.303±0.123

=0.003)

and was much higher in those with distant metastasis than those without (M

: 0.017±0.071

0.636±0.296

=0.003); and the patients with high expression of IDS had poor prognosis (overall survival:

=0.008; disease-free survival:

=0.007). COX regression analysis indicated that the mRNA expression of IDS was an independent predictors of colorectal cancer prognosis (

=0.014

Hazard ratio=2.651

95%

: 1.217~5.775). The results of immunohistochemical analysis for the 50 cases showed that the expression of IDS was higher in colorectal cancer patients with lymph node metastasis than those without (N

1-3

: 27.324±0.698

40.674±3.528

=3.0×10

-5

)

and was higher in those with distant metastasis than those without (M

: 27.941±0.952

39.320±3.467

=1.2×10

-5

)

and the patients with high IDS expression suggested poor prognosis (

=7.2×10

-5

). COX regression analysis also suggested that IDS expression was an independ

ent predictor of colorectal cancer prognosis (

=0.008

Hazard ratio=5.847

95%

: 1.585~21.568).

Conclusion

The colorectal cancer patients with high expression of IDS is associated with high risk of metastasis and poor prognosis. The molecule could be regarded as an independent predictor of colorectal cancer patients.

关键词

Keywords

references

BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.

YU W Y, JIANG J F, XIE L L, et al . Mortality trends in colorectal cancer in China during 2000-2015: A joinpoint regression and age-period-cohort analysis[J ] . Prev Chronic Dis, 2018, 15: E156. DOI:10.5888/pcd15.180329.

DAVIDSON S M, VANDER HEIDEN M G. Critical functions of the lysosome in cancer biology[J]. Annu Rev Pharmacol Toxicol, 2017, 57: 481-507. DOI:10.1146/annurev-pharmtox-010715-103101.

TOWERS C G, THORBURN A. Targeting the lysosome for cancer therapy[J]. Cancer Discov, 2017, 7(11): 1218-1220. DOI:10.1158/2159-8290.CD-17-0996.

ZHOU W H, GONG L, WU Q C, et al . PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial- mesenchymal transition and metastasis in hepatocellular carcinoma[J ] . J Exp Clin Cancer Res, 2018, 37(1): 215. DOI:10.1186/s13046-018-0890-4.

LIU H, MA Y, HE H W, et al . SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells[J ] . Autophagy, 2017, 13(5): 900-913. DOI:10.1080/15548627.2017.1291479.

ZHAO T, DING X C, YAN C, et al . Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice[J ] . J Biol Chem, 2017, 292(47): 19198-19208. DOI:10.1074/jbc.M116.773093.

KUNDU S T, GRZESKOWIAK C L, FRADETTE J J, et al . TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins[J ] . Nat Commun, 2018, 9(1): 2731. DOI:10.1038/s41467-018-05013-x.

KIM S M, KIM Y, JEONG K, et al . Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography[J ] . Ultrasonography, 2018, 37(1): 36-42. DOI:10.14366/usg.16045.

HOLMES R S. Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene[J]. 3 Biotech, 2017, 7(1): 22. DOI:10.1007/s13205-016-0595-3.

SMITH C M, FINGER J H, HAYAMIZU T F, et al . The mouse gene expression database (GXD): 2014 update[J ] . Nucleic Acids Res, 2014, 42(Database issue): D818-D824. DOI:10.1093/nar/gkt954.

DA SILVA E M, STRUFALDI M W, ANDRIOLO R B, et al . Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type Ⅱ (Hunter syndrome)[J ] . Cochrane Database Syst Rev, 2016, 2: CD008185. DOI:10.1002/14651858.CD008185.pub4.

MEDEIROS M G, FERREIRA T M, LEITE E L, et al . New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus[J ] . Comp Biochem Phys B, 1998, 119(3): 539-547.

PASQUALINI J R. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer[J]. Zentralbl Gynakol, 1997, 119(Suppl 2): 48-53.

AHMED S, OWEN C P, JAMES K, et al . Review of estrone sulfatase and its inhibitors: An important new target against hormone dependent breast cancer[J ] . Curr Med Chem, 2002, 9(2): 263-273.

NAKAMURA Y, SUZUKI T, FUKUDA T, et al . Steroid sulfatase and estrogen sulfotransferase in human prostate cancer[J ] . Prostate, 2006, 66(9): 1005-1012. DOI:10.1002/pros.20426.

CHURA J C, BLOMQUIST C H, RYU H S, et al . Estrone sulfatase activity in patients with advanced ovarian cancer[J ] . Gynecol Oncol, 2009, 112(1): 205-209. DOI:10.1016/j.ygyno.2008.08.037.

SHAH R, SINGH J, SINGH D, et al . Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review[J ] . Eur J Med Chem, 2016, 114: 170-190. DOI:10.1016/j.ejmech.2016.02.054.

PUROHIT A, REED M J, MORRIS N C, et al . Regulation and inhibition of steroid sulfatase activity in breast cancer[J ] . Ann N Y Acad Sci, 1996, 784: 40-49.

WADE A N, ENGLER J R, TRAN V M, et al . Measuring sulfatase expression and invasion in glioblastoma[J ] . Methods Mol Biol, 2015, 1229: 507-516. DOI:10.1007/978-1-4939-1714-3_39.

PRINZ R D, WILLIS C M, VILORIA-PETIT A, et al . Elimination of breast tumor-associated chondroitin sulfate promotes metastasis[J ] . Genet Mol Res, 2011, 10(4): 3901-3913. DOI:10.4238/2011.December.8.9.

WILLIS C M, KLVPPEL M. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells[J]. PLoS ONE, 2014, 9(8): e103966. DOI:10.1371/journal.pone.0103966.

TADEO I, GAMERO-SANDEMETRIO E, BERBEGALL A P, et al . 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors[J ] . Histol Histopathol, 2018, 33(5): 487-495. DOI:10.14670/HH-11-947.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

细胞外基质蛋白1在结直肠癌中的表达和临床意义

PRR11在结直肠癌中的表达及其对结直肠癌侵袭和转移的影响

miR-543/SNTB1轴调控结直肠癌免疫微环境

免疫治疗联合靶向治疗及化疗在微卫星稳定型转移性结直肠癌患者三线治疗中的疗效和安全性

缺氧诱导因子-1α纳米抑制剂的构建及在逆转结直肠癌细胞化疗耐药中的应用